Showing 1771 - 1780 of 2250 results

Showing Results for: “Glycemic Index and Diabetes”

Section 504 Plan

Discover a comprehensive list of services and modifications in our sample 504 Plan for students with diabetes.

College

Find valuable resources and legal protections for college students with diabetes to ensure fair treatment and understanding of their rights.

Frequently Asked Questions about the Better Choices for Life Program

Find out answers to questions about Better Choices for Life program offered by American Diabetes Association.

Federal Advocacy

Learn more on how ADA help to achieve federal legislative goals that allow people with diabetes coverage for and access to the treatments and services.

Meet Serena

Meet Serena- living with diabetes who finds purpose in helping others find the information they need to live healthy lives.

Breaking News

Get the latest diabetes-related news from this page- your one-stop shop to get quick information about what is happening.

An Exciting New Era of Scientific Progress and Innovative Care for People with Diabetes Begins Under New Chief Scientific & Medical Officer, Robert A. Gabbay, MD, PhD

On July 1, 2020 Dr. Gabbay will begin his tenure at the American Diabetes Association ® The American Diabetes Association (ADA) is pleased to announce that Robert A. Gabbay, MD, PhD has been named Chief Scientific & Medical Officer (CSMO). Dr. Gabbay is internationally renowned and brings vast knowledge in diabetes clinical care and management, innovative research and thought leadership to the ADA’s executive team. Since 2014, Dr. Gabbay has served as the Chief Medical Officer and Senior Vice President at Joslin Diabetes Center, and Associate Professor at Harvard Medical School. He oversaw the

Three ADA Pathway Grant Awardees’ Collaborative Breakthrough: Analysis Describing the Genetic Link Between Beta (β) Cell Function and Type 2 Diabetes Published in Cell Reports

American Diabetes Association (ADA) Pathway to Stop Diabetes® grant recipients Michael L. Stitzel, PhD, of the Jackson Laboratory, Stephen C.J. Parker, PhD, of the University of Michigan, and Praveen Sethupathy, PhD, of Cornell University, recently embarked on a collaborative research initiative empowered by the ADA Pathway to Stop Diabetes program. Bringing together diverse areas of expertise, their collaboration led to today’s report that establishes new detail about the genetic signatures of the cells that produce and release insulin, pancreatic beta (β) cells. The research, detailed in the

Insulin Pumps: Relief and Choice

Find out more why insulin pumps are a relief and choice for people living with diabetes.

Project Power

As a no-cost lifestyle change program, Project Power empowers adults and children to reduce their risk or manage and thrive with type 2 diabetes.